A. Sebelipase Alfa (Recombinant, 20 Mg, 10 Ml/Bottle) 138 Bottles, B. Eculizumab (Recombinant, 300 Mg, 30 Ml/Bottle) 1 Bottle, C. Nusinersen Sodium (12 Mg/Bottle) 1 Bottle, D. Cetuximab Sarcoplasmic Reductase (Sarcoplasmic Reductase) 1 Bottle, D.

国立大学法人 Japan has Released a tender for A. Sebelipase Alfa (Recombinant, 20 Mg, 10 Ml/Bottle) 138 Bottles, B. Eculizumab (Recombinant, 300 Mg, 30 Ml/Bottle) 1 Bottle, C. Nusinersen Sodium (12 Mg/Bottle) 1 Bottle, D. Cetuximab Sarcoplasmic Reductase (Sarcoplasmic Reductase) 1 Bottle, D. in Healthcare and Medicine. The tender was released on Feb 03, 2025.

Country - Japan

Summary - A. Sebelipase Alfa (Recombinant, 20 Mg, 10 Ml/Bottle) 138 Bottles, B. Eculizumab (Recombinant, 300 Mg, 30 Ml/Bottle) 1 Bottle, C. Nusinersen Sodium (12 Mg/Bottle) 1 Bottle, D. Cetuximab Sarcoplasmic Reductase (Sarcoplasmic Reductase) 1 Bottle, D.

Deadline - Feb 18, 2025

GT reference number - 102636915

Product classification - Medical equipments, pharmaceuticals and personal care products